Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics

Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics

Thumbnail Image
Download
Name

nihms588687.pdf

Description
Accepted version
Size

2.8 MB

Format

Adobe PDF

Checksum (MD5)

771f3ea2c86253687c6903b1d2be4544

sword-2019-09-05T15:56:46.original.xml (130 B)
Original SWORD entry document
Author(s)
Kim, YongTae
•
Fay, Francois
•
Cormode, David P
•
Sanchez-Gaytan, Brenda L
•
Tang, Jun
•
Hennessy, Elizabeth J
•
Ma, Mingming
•
Moore, Kathryn
•
Farokhzad, Omid C
•
Fisher, Edward Allen
more
Date Issued
2013
Journal
ACS Nano
Publisher
American Chemical Society (ACS)
Citation
Kim, Y., et al. "Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics." ACS Nano 7 11 (2013): 9975-83.
Version
Author's final manuscript
Abstract
High-density lipoprotein (HDL) is a natural nanoparticle that transports peripheral cholesterol to the liver. Reconstituted high-density lipoprotein (rHDL) exhibits antiatherothrombotic properties and is being considered as a natural treatment for cardiovascular diseases. Furthermore, HDL nanoparticle platforms have been created for targeted delivery of therapeutic and diagnostic agents. The current methods for HDL reconstitution involve lengthy procedures that are challenging to scale up. A central need in the synthesis of rHDL, and multifunctional nanomaterials in general, is to establish large-scale production of reproducible and homogeneous batches in a simple and efficient fashion. Here, we present a large-scale microfluidics-based manufacturing method for single-step synthesis of HDL-mimicking nanomaterials (μHDL). μHDL is shown to have the same properties (e.g., size, morphology, bioactivity) as conventionally reconstituted HDL and native HDL. In addition, we were able to incorporate simvastatin (a hydrophobic drug) into μHDL, as well as gold, iron oxide, quantum dot nanocrystals or fluorophores to enable its detection by computed tomography (CT), magnetic resonance imaging (MRI), or fluorescence microscopy, respectively. Our approach may contribute to effective development and optimization of lipoprotein-based nanomaterials for medical imaging and drug delivery. © 2013 American Chemical Society.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
https://hdl.handle.net/1721.1/134496
DOI of Published Version
https://doi.org/10.1021/NN4039063
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.